Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (28)
Sarah Jafrin, Md. Abdul Aziz, Md. Sajal, Tarzina Akter, Chaity Das, Tahmina Akter, Md. Saddam Hussain, Md. Shalahuddin Millat, Mohammad Sarowar Uddin, Nura Ershad Naznin, Md. Sharif Reza, Abdullah Al Maruf, Saleh Salem Baeesa, Ghulam Md Ashraf & Mohammad Safiqul Islam. (2023) ZNF804A intronic variant rs1344706 and NGRN rs12807809 genetic polymorphisms and risk of schizophrenia in Bangladesh. Human Gene 36, pages 201175.
Crossref
Crossref
Pushpendra D. Pratap, Syed Tasleem Raza, Ghazala Zaidi, Shipra Kunwar, Sharique Ahmad, Mark Rector Charles, Ale Eba & Muneshwar Rajput. (2022) Genetic Variants in Interleukin-10 Gene Association with Susceptibility and Cervical Cancer Development: A Case Control Study. Global Medical Genetics 09:02, pages 129-140.
Crossref
Crossref
O. Bulgakova, A. Kussainova & R. Bersimbaev. (2020) The cell cycle regulatory gene polymorphisms TP53 (rs1042522) and MDM2 (rs2279744) in lung cancer: a meta-analysis. Vavilov Journal of Genetics and Breeding 24:7, pages 77-784.
Crossref
Crossref
Anamika Datta, Fatema Tuz Zahora, Md. Abdul Aziz, Mohammad Sarowar Uddin, Mahmuda Ferdous, Md. Shalahuddin Millat, Md. Shahid Sarwar, Md. Abdul Barek, Sarah Jafrin, Shamsun Nahar & Mohammad Safiqul Islam. (2020) Association study of IL10 gene polymorphisms (rs1800872 and rs1800896) with cervical cancer in the Bangladeshi women. International Immunopharmacology 89, pages 107091.
Crossref
Crossref
Ausra Stumbryte, Zivile Gudleviciene, Gabrielis Kundrotas, Daiva Dabkeviciene, Agne Kunickaite & Saulius Cicenas. (2017)
Individual and combined effect of
TP53, MDM2, MDM4, MTHFR, CCR5,
and
CASP8
gene polymorphisms in lung cancer
. Oncotarget 9:3, pages 3214-3229.
Crossref
Crossref
Debmalya Sengupta, Udayan Guha, Samsiddhi Bhattacharjee & Mainak Sengupta. (2017) Association of 12 polymorphic variants conferring genetic risk to lung cancer in Indian population: An extensive meta-analysis. Environmental and Molecular Mutagenesis 58:9, pages 688-700.
Crossref
Crossref
Ankita Kumari, Charu Bahl, Navneet Singh, Digambar Behera & Siddharth Sharma. (2016) Association of p53 codon 72 polymorphism and survival of North Indian lung cancer patients treated with platinum-based chemotherapy. Molecular Biology Reports 43:12, pages 1383-1394.
Crossref
Crossref
Xu Wang, Lina Jin, Jiuwei Cui, Kewei Ma, Xiao Chen & Wei Li. (2015)
Mouse double minute-2 homolog (
MDM2
)-rs2279744 polymorphism associated with lung cancer risk in a Northeastern Chinese population
. Thoracic Cancer 6:1, pages 91-96.
Crossref
Crossref
Md. Shaki Mostaid, Maizbha Uddin Ahmed, Mohammad Safiqul Islam, Muhammad Shahdaat Bin Sayeed & Abul Hasnat. (2014) Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population. Tumor Biology 35:10, pages 10309-10317.
Crossref
Crossref
Raju K. Mandal, Suraj S. Yadav & Aditya K. Panda. (2014) No evidence of correlation between p53 codon 72 G > C gene polymorphism and cancer risk in Indian population: a meta-analysis. Tumor Biology 35:9, pages 8607-8613.
Crossref
Crossref
Mohammad Nabavi, Abbas Ghaderi, Mohammad Javad Fattahi, N. Danaie, R. Zangooie & Mohammad Faranoush. (2014) Association between p53 codon 72 polymorphism and systemic lupus erythematosus. Rheumatology 52:2, pages 94-98.
Crossref
Crossref
Xu Wang, Yi-Zhuo Wang, Ke-Wei Ma, Xiao Chen & Wei Li. (2014) <b><i>MDM2</i></b> rs2279744 and <b><i>TP53</i></b> rs1042522 Polymorphisms Associated with Etoposide- and Cisplatin-Induced Grade III/IV Neutropenia in Chinese Extensive-Stage Small-Cell Lung Cancer Patients. Oncology Research and Treatment 37:4, pages 176-180.
Crossref
Crossref
Xiang-Hua Ye, Zhi-Bin Bu, Jie Feng, Ling Peng, Xin-Biao Liao, Xin-Li Zhu, Xiao-li Sun, Hao-Gang Yu, Dan-Fang Yan & Sen-Xiang Yan. (2013) Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis. Molecular Biology Reports 41:1, pages 373-385.
Crossref
Crossref
Chao Zhou, Hao Chen & An Wang. (2013) P53 codon 72 polymorphism and lung cancer risk: evidence from 27,958 subjects. Tumor Biology 34:5, pages 2961-2969.
Crossref
Crossref
Qian Qiao & Weiguo Hu. (2013) The Association Between TP53 Arg72Pro Polymorphism and Lung Cancer Susceptibility: Evidence from 30,038 Subjects. Lung 191:4, pages 369-377.
Crossref
Crossref
Anup R. TilakSachin KumarMohan C. PantNeeraj MathurAshwani Kumar. (2013)
Polymorphism
Arg72Pro
of
p53
Confers Susceptibility to Squamous Cell Carcinoma of Lungs in a North Indian Population
. DNA and Cell Biology 32:2, pages 66-72.
Crossref
Crossref
Hellen Silva Cintra, Juliana Castro Dourado Pinezi, Graziella Dias Pinheiro Machado, Gustavo Moura de Carvalho, Ana Terra Silva Carvalho, Thalles Eduardo Dias dos Santos, Ricardo Duarte Marciano & Renata de Bastos Ascenço Soares. (2013) Investigation of Genetic Polymorphisms Related to the Outcome of Radiotherapy for Prostate Cancer Patients. Disease Markers 35, pages 701-710.
Crossref
Crossref
X.F. Chen, S. Cai, Q.G. Chen, Z.H. Ni, J.H. Tang, D.W. Xu & X.B. Wang. (2012) Multiple variants of TERT and CLPTM1L constitute risk factors for lung adenocarcinoma. Genetics and Molecular Research 11:1, pages 370-378.
Crossref
Crossref
W. W. Xun, P. Brennan, A. Tjonneland, U. Vogel, K. Overvad, R. Kaaks, F. Canzian, H. Boeing, A. Trichopoulou, E. Oustoglou, Z. Giotaki, M. Johansson, D. Palli, C. Agnoli, R. Tumino, C. Sacerdote, S. Panico, H. B. Bueno-de-Mesquita, P. H. M. Peeters, E. Lund, M. Kumle, L. Rodriguez, A. Agudo, M.-J. Sanchez, L. Arriola, M.-D. Chirlaque, A. Barricarte, G. Hallmans, T. Rasmuson, K.-T. Khaw, N. Wareham, T. Key, E. Riboli & P. Vineis. (2011) Single-nucleotide polymorphisms (5p15.33, 15q25.1, 6p22.1, 6q27 and 7p15.3) and lung cancer survival in the European Prospective Investigation into Cancer and Nutrition (EPIC). Mutagenesis 26:5, pages 657-666.
Crossref
Crossref
Jin-Mei Piao, Hee Nam Kim, Hye-Rim Song, Sun-Seog Kweon, Jin-Su Choi, Woo-Jun Yun, Young-Chul Kim, In-Jae Oh, Kyu-Sik Kim & Min-Ho Shin. (2011) p53 codon 72 polymorphism and the risk of lung cancer in a Korean population. Lung Cancer 73:3, pages 264-267.
Crossref
Crossref
Rakhshan IhsanThoudam Regina DeviDhirendra Singh YadavAshwani Kumar MishraJagannath SharmaEric ZomawiaYogesh VermaRupkumar PhukanJagadish MahantaAmal Chandra KatakiSujala KapurSunita Saxena. (2011)
Investigation on the Role of
p53
Codon 72 Polymorphism and Interactions with Tobacco, Betel Quid, and Alcohol in Susceptibility to Cancers in a High-Risk Population from North East India
. DNA and Cell Biology 30:3, pages 163-171.
Crossref
Crossref
Anne M. Horgan, Boming Yang, Abul Kalam Azad, Eitan Amir, Thomas John, David W. Cescon, Paul Wheatley-Price, Rayjean J. Hung, Frances A. Shepherd & Geoffrey Liu. (2011) Pharmacogenetic and Germline Prognostic Markers of Lung Cancer. Journal of Thoracic Oncology 6:2, pages 296-304.
Crossref
Crossref
Ayse Engin, Bensu Karahalil, Ali Karakaya & Atilla Engin. (2011) Association Between XRCC1 ARG399GLN and P53 ARG72PRO Polymorphisms and the Risk of Gastric and Colorectal Cancer in Turkish Population. Archives of Industrial Hygiene and Toxicology 62:3.
Crossref
Crossref
Ravindran Ankathil. (2010) Tobacco, Genetic Susceptibility and Lung cancer. Tobacco Use Insights 3, pages TUI.S2819.
Crossref
Crossref
Lili Yan, Deqiang Zhang, Chengwen Chen, Yumin Mao, Yi Xie, Yao Li, Yan Huang & Baohui Han. (2009)
TP53
Arg72Pro polymorphism and lung cancer risk: A meta-analysis
. International Journal of Cancer 125:12, pages 2903-2911.
Crossref
Crossref
Yan Li, Li-Xin Qiu, Xiao-Kun Shen, Xiao-Jing Lv, Xiao-Ping Qian & Yong Song. (2009) A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: Evidence from 15,857 subjects. Lung Cancer 66:1, pages 15-21.
Crossref
Crossref
Tomasz Zemleduch, Margarita Lianeri, Małgorzata Rydzanicz, Marzena Gajęcka, Krzysztof Szyfter & Paweł P. Jagodziński. (2009) Contribution of polymorphism in codon 72 of TP53 gene to laryngeal cancer in Polish patients. Oral Oncology 45:8, pages 683-686.
Crossref
Crossref
Shengming Dai, Chen Mao, Lijun Jiang, Guisheng Wang & Hongge Cheng. (2009) P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case–control studies. Human Genetics 125:5-6, pages 633-638.
Crossref
Crossref